Underutilization of nirmatrelvir/ritonavir in eligible COVID-19 patients Article Swipe
Celia Fortea de Arpe
,
Reynaldo Homen
,
Adrián Valls Carbó
,
Julia Barrado
,
Carolina Olmos‐Mata
,
Juncal Pérez‐Somarriba
,
Ana Muñoz‐Gómez
,
M.J. Nuñez-Orantos
,
Noemí Cabello‐Clotet
,
Vicente Estrada
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1007/s10096-025-05150-4
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1007/s10096-025-05150-4
Related Topics
Concepts
Ritonavir
Coronavirus disease 2019 (COVID-19)
Medical microbiology
Medicine
2019-20 coronavirus outbreak
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Virology
Betacoronavirus
Internal medicine
Intensive care medicine
Human immunodeficiency virus (HIV)
Antiretroviral therapy
Viral load
Infectious disease (medical specialty)
Disease
Outbreak
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1007/s10096-025-05150-4
- https://link.springer.com/content/pdf/10.1007/s10096-025-05150-4.pdf
- OA Status
- hybrid
- References
- 9
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4411282265
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4411282265Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1007/s10096-025-05150-4Digital Object Identifier
- Title
-
Underutilization of nirmatrelvir/ritonavir in eligible COVID-19 patientsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-06-13Full publication date if available
- Authors
-
Celia Fortea de Arpe, Reynaldo Homen, Adrián Valls Carbó, Julia Barrado, Carolina Olmos‐Mata, Juncal Pérez‐Somarriba, Ana Muñoz‐Gómez, M.J. Nuñez-Orantos, Noemí Cabello‐Clotet, Vicente EstradaList of authors in order
- Landing page
-
https://doi.org/10.1007/s10096-025-05150-4Publisher landing page
- PDF URL
-
https://link.springer.com/content/pdf/10.1007/s10096-025-05150-4.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://link.springer.com/content/pdf/10.1007/s10096-025-05150-4.pdfDirect OA link when available
- Concepts
-
Ritonavir, Coronavirus disease 2019 (COVID-19), Medical microbiology, Medicine, 2019-20 coronavirus outbreak, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Virology, Betacoronavirus, Internal medicine, Intensive care medicine, Human immunodeficiency virus (HIV), Antiretroviral therapy, Viral load, Infectious disease (medical specialty), Disease, OutbreakTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
9Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4411282265 |
|---|---|
| doi | https://doi.org/10.1007/s10096-025-05150-4 |
| ids.doi | https://doi.org/10.1007/s10096-025-05150-4 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40512249 |
| ids.openalex | https://openalex.org/W4411282265 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000627 |
| mesh[1].descriptor_ui | D019438 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | therapeutic use |
| mesh[1].descriptor_name | Ritonavir |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D008297 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Male |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000093485 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | COVID-19 Drug Treatment |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D005260 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Female |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D008875 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Middle Aged |
| mesh[6].qualifier_ui | Q000627 |
| mesh[6].descriptor_ui | D000998 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | therapeutic use |
| mesh[6].descriptor_name | Antiviral Agents |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D000368 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Aged |
| mesh[8].qualifier_ui | Q000187 |
| mesh[8].descriptor_ui | D000086402 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | drug effects |
| mesh[8].descriptor_name | SARS-CoV-2 |
| mesh[9].qualifier_ui | Q000401 |
| mesh[9].descriptor_ui | D000086382 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | mortality |
| mesh[9].descriptor_name | COVID-19 |
| mesh[10].qualifier_ui | Q000706 |
| mesh[10].descriptor_ui | D006760 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | statistics & numerical data |
| mesh[10].descriptor_name | Hospitalization |
| mesh[11].qualifier_ui | Q000031 |
| mesh[11].descriptor_ui | D011392 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | analogs & derivatives |
| mesh[11].descriptor_name | Proline |
| mesh[12].qualifier_ui | Q000627 |
| mesh[12].descriptor_ui | D011392 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | therapeutic use |
| mesh[12].descriptor_name | Proline |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000328 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Adult |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D004347 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Drug Interactions |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D000369 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Aged, 80 and over |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D012189 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Retrospective Studies |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D004338 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Drug Combinations |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D007769 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Lactams |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D007930 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Leucine |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D009570 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Nitriles |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006801 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Humans |
| mesh[22].qualifier_ui | Q000627 |
| mesh[22].descriptor_ui | D019438 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | therapeutic use |
| mesh[22].descriptor_name | Ritonavir |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D008297 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Male |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D000093485 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | COVID-19 Drug Treatment |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D005260 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Female |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D008875 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Middle Aged |
| mesh[27].qualifier_ui | Q000627 |
| mesh[27].descriptor_ui | D000998 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | therapeutic use |
| mesh[27].descriptor_name | Antiviral Agents |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D000368 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Aged |
| mesh[29].qualifier_ui | Q000187 |
| mesh[29].descriptor_ui | D000086402 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | drug effects |
| mesh[29].descriptor_name | SARS-CoV-2 |
| mesh[30].qualifier_ui | Q000401 |
| mesh[30].descriptor_ui | D000086382 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | mortality |
| mesh[30].descriptor_name | COVID-19 |
| mesh[31].qualifier_ui | Q000706 |
| mesh[31].descriptor_ui | D006760 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | statistics & numerical data |
| mesh[31].descriptor_name | Hospitalization |
| mesh[32].qualifier_ui | Q000031 |
| mesh[32].descriptor_ui | D011392 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | analogs & derivatives |
| mesh[32].descriptor_name | Proline |
| mesh[33].qualifier_ui | Q000627 |
| mesh[33].descriptor_ui | D011392 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | therapeutic use |
| mesh[33].descriptor_name | Proline |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D000328 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Adult |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D004347 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Drug Interactions |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D000369 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Aged, 80 and over |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D012189 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Retrospective Studies |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D004338 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Drug Combinations |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D007769 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Lactams |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D007930 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Leucine |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D009570 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Nitriles |
| type | article |
| title | Underutilization of nirmatrelvir/ritonavir in eligible COVID-19 patients |
| biblio.issue | 9 |
| biblio.volume | 44 |
| biblio.last_page | 2286 |
| biblio.first_page | 2283 |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9993000030517578 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T13201 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9943000078201294 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | Infectious Encephalopathies and Encephalitis |
| topics[2].id | https://openalex.org/T10613 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9883999824523926 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1311 |
| topics[2].subfield.display_name | Genetics |
| topics[2].display_name | Virus-based gene therapy research |
| is_xpac | False |
| apc_list.value | 3390 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4390 |
| apc_paid.value | 3390 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 4390 |
| concepts[0].id | https://openalex.org/C2779298103 |
| concepts[0].level | 5 |
| concepts[0].score | 0.8234096765518188 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q422618 |
| concepts[0].display_name | Ritonavir |
| concepts[1].id | https://openalex.org/C3008058167 |
| concepts[1].level | 4 |
| concepts[1].score | 0.7844926118850708 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[1].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[2].id | https://openalex.org/C190139176 |
| concepts[2].level | 2 |
| concepts[2].score | 0.7625293731689453 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q598976 |
| concepts[2].display_name | Medical microbiology |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.6313783526420593 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C3006700255 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6076120138168335 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q81068910 |
| concepts[4].display_name | 2019-20 coronavirus outbreak |
| concepts[5].id | https://openalex.org/C3007834351 |
| concepts[5].level | 5 |
| concepts[5].score | 0.5808603763580322 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[5].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[6].id | https://openalex.org/C159047783 |
| concepts[6].level | 1 |
| concepts[6].score | 0.49682334065437317 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[6].display_name | Virology |
| concepts[7].id | https://openalex.org/C2778137277 |
| concepts[7].level | 5 |
| concepts[7].score | 0.4173264503479004 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q16532287 |
| concepts[7].display_name | Betacoronavirus |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.4054492115974426 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C177713679 |
| concepts[9].level | 1 |
| concepts[9].score | 0.33020204305648804 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[9].display_name | Intensive care medicine |
| concepts[10].id | https://openalex.org/C3013748606 |
| concepts[10].level | 2 |
| concepts[10].score | 0.22523799538612366 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q15787 |
| concepts[10].display_name | Human immunodeficiency virus (HIV) |
| concepts[11].id | https://openalex.org/C2993143319 |
| concepts[11].level | 4 |
| concepts[11].score | 0.14600062370300293 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q583050 |
| concepts[11].display_name | Antiretroviral therapy |
| concepts[12].id | https://openalex.org/C142462285 |
| concepts[12].level | 3 |
| concepts[12].score | 0.13008743524551392 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q2528140 |
| concepts[12].display_name | Viral load |
| concepts[13].id | https://openalex.org/C524204448 |
| concepts[13].level | 3 |
| concepts[13].score | 0.09544879198074341 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[13].display_name | Infectious disease (medical specialty) |
| concepts[14].id | https://openalex.org/C2779134260 |
| concepts[14].level | 2 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[14].display_name | Disease |
| concepts[15].id | https://openalex.org/C116675565 |
| concepts[15].level | 2 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q3241045 |
| concepts[15].display_name | Outbreak |
| keywords[0].id | https://openalex.org/keywords/ritonavir |
| keywords[0].score | 0.8234096765518188 |
| keywords[0].display_name | Ritonavir |
| keywords[1].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[1].score | 0.7844926118850708 |
| keywords[1].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[2].id | https://openalex.org/keywords/medical-microbiology |
| keywords[2].score | 0.7625293731689453 |
| keywords[2].display_name | Medical microbiology |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.6313783526420593 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/2019-20-coronavirus-outbreak |
| keywords[4].score | 0.6076120138168335 |
| keywords[4].display_name | 2019-20 coronavirus outbreak |
| keywords[5].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[5].score | 0.5808603763580322 |
| keywords[5].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[6].id | https://openalex.org/keywords/virology |
| keywords[6].score | 0.49682334065437317 |
| keywords[6].display_name | Virology |
| keywords[7].id | https://openalex.org/keywords/betacoronavirus |
| keywords[7].score | 0.4173264503479004 |
| keywords[7].display_name | Betacoronavirus |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.4054492115974426 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[9].score | 0.33020204305648804 |
| keywords[9].display_name | Intensive care medicine |
| keywords[10].id | https://openalex.org/keywords/human-immunodeficiency-virus |
| keywords[10].score | 0.22523799538612366 |
| keywords[10].display_name | Human immunodeficiency virus (HIV) |
| keywords[11].id | https://openalex.org/keywords/antiretroviral-therapy |
| keywords[11].score | 0.14600062370300293 |
| keywords[11].display_name | Antiretroviral therapy |
| keywords[12].id | https://openalex.org/keywords/viral-load |
| keywords[12].score | 0.13008743524551392 |
| keywords[12].display_name | Viral load |
| keywords[13].id | https://openalex.org/keywords/infectious-disease |
| keywords[13].score | 0.09544879198074341 |
| keywords[13].display_name | Infectious disease (medical specialty) |
| language | en |
| locations[0].id | doi:10.1007/s10096-025-05150-4 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S130127385 |
| locations[0].source.issn | 0934-9723, 1435-4373 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0934-9723 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | European Journal of Clinical Microbiology & Infectious Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310319900 |
| locations[0].source.host_organization_name | Springer Science+Business Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://link.springer.com/content/pdf/10.1007/s10096-025-05150-4.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | European Journal of Clinical Microbiology & Infectious Diseases |
| locations[0].landing_page_url | https://doi.org/10.1007/s10096-025-05150-4 |
| locations[1].id | pmid:40512249 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40512249 |
| locations[2].id | pmh:oai:europepmc.org:11266367 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12457550 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5118142212 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Celia Fortea de Arpe |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2961216182 |
| authorships[0].affiliations[0].raw_affiliation_string | Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[0].institutions[0].id | https://openalex.org/I2961216182 |
| authorships[0].institutions[0].ror | https://ror.org/04d0ybj29 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I2961216182, https://openalex.org/I4210139293 |
| authorships[0].institutions[0].country_code | ES |
| authorships[0].institutions[0].display_name | Hospital Clínico San Carlos |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Celia Fortea de Arpe |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[1].author.id | https://openalex.org/A5112909970 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2307-5078 |
| authorships[1].author.display_name | Reynaldo Homen |
| authorships[1].countries | ES |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2961216182 |
| authorships[1].affiliations[0].raw_affiliation_string | Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I4210115082 |
| authorships[1].affiliations[1].raw_affiliation_string | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain. |
| authorships[1].institutions[0].id | https://openalex.org/I4210115082 |
| authorships[1].institutions[0].ror | https://ror.org/02g87qh62 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4387152914 |
| authorships[1].institutions[0].country_code | ES |
| authorships[1].institutions[0].display_name | Centro de Investigación Biomédica en Red |
| authorships[1].institutions[1].id | https://openalex.org/I2961216182 |
| authorships[1].institutions[1].ror | https://ror.org/04d0ybj29 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I2961216182, https://openalex.org/I4210139293 |
| authorships[1].institutions[1].country_code | ES |
| authorships[1].institutions[1].display_name | Hospital Clínico San Carlos |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Reynaldo Homen |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain., Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[2].author.id | https://openalex.org/A5061087163 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-4831-1276 |
| authorships[2].author.display_name | Adrián Valls Carbó |
| authorships[2].countries | ES |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210115082 |
| authorships[2].affiliations[0].raw_affiliation_string | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain. |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I2961216182 |
| authorships[2].affiliations[1].raw_affiliation_string | Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[2].institutions[0].id | https://openalex.org/I4210115082 |
| authorships[2].institutions[0].ror | https://ror.org/02g87qh62 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4387152914 |
| authorships[2].institutions[0].country_code | ES |
| authorships[2].institutions[0].display_name | Centro de Investigación Biomédica en Red |
| authorships[2].institutions[1].id | https://openalex.org/I2961216182 |
| authorships[2].institutions[1].ror | https://ror.org/04d0ybj29 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I2961216182, https://openalex.org/I4210139293 |
| authorships[2].institutions[1].country_code | ES |
| authorships[2].institutions[1].display_name | Hospital Clínico San Carlos |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Adrian Valls-Carbó |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain., Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[3].author.id | https://openalex.org/A5114516243 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Julia Barrado |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I2961216182 |
| authorships[3].affiliations[0].raw_affiliation_string | Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[3].institutions[0].id | https://openalex.org/I2961216182 |
| authorships[3].institutions[0].ror | https://ror.org/04d0ybj29 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I2961216182, https://openalex.org/I4210139293 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Hospital Clínico San Carlos |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Julia Barrado |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[4].author.id | https://openalex.org/A5118142213 |
| authorships[4].author.orcid | https://orcid.org/0009-0001-9037-4377 |
| authorships[4].author.display_name | Carolina Olmos‐Mata |
| authorships[4].countries | ES |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I2961216182 |
| authorships[4].affiliations[0].raw_affiliation_string | Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[4].institutions[0].id | https://openalex.org/I2961216182 |
| authorships[4].institutions[0].ror | https://ror.org/04d0ybj29 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I2961216182, https://openalex.org/I4210139293 |
| authorships[4].institutions[0].country_code | ES |
| authorships[4].institutions[0].display_name | Hospital Clínico San Carlos |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Carolina Olmos-Mata |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[5].author.id | https://openalex.org/A5051478940 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Juncal Pérez‐Somarriba |
| authorships[5].countries | ES |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2961216182 |
| authorships[5].affiliations[0].raw_affiliation_string | Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I4210115082 |
| authorships[5].affiliations[1].raw_affiliation_string | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain. |
| authorships[5].institutions[0].id | https://openalex.org/I4210115082 |
| authorships[5].institutions[0].ror | https://ror.org/02g87qh62 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4387152914 |
| authorships[5].institutions[0].country_code | ES |
| authorships[5].institutions[0].display_name | Centro de Investigación Biomédica en Red |
| authorships[5].institutions[1].id | https://openalex.org/I2961216182 |
| authorships[5].institutions[1].ror | https://ror.org/04d0ybj29 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I2961216182, https://openalex.org/I4210139293 |
| authorships[5].institutions[1].country_code | ES |
| authorships[5].institutions[1].display_name | Hospital Clínico San Carlos |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Juncal Pérez-Somarriba |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain., Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[6].author.id | https://openalex.org/A5071744285 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-0109-9594 |
| authorships[6].author.display_name | Ana Muñoz‐Gómez |
| authorships[6].countries | ES |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I2961216182 |
| authorships[6].affiliations[0].raw_affiliation_string | Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I4210115082 |
| authorships[6].affiliations[1].raw_affiliation_string | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain. |
| authorships[6].institutions[0].id | https://openalex.org/I4210115082 |
| authorships[6].institutions[0].ror | https://ror.org/02g87qh62 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4387152914 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | Centro de Investigación Biomédica en Red |
| authorships[6].institutions[1].id | https://openalex.org/I2961216182 |
| authorships[6].institutions[1].ror | https://ror.org/04d0ybj29 |
| authorships[6].institutions[1].type | healthcare |
| authorships[6].institutions[1].lineage | https://openalex.org/I2961216182, https://openalex.org/I4210139293 |
| authorships[6].institutions[1].country_code | ES |
| authorships[6].institutions[1].display_name | Hospital Clínico San Carlos |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Ana Muñoz-Gomez |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain., Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[7].author.id | https://openalex.org/A5109684431 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | M.J. Nuñez-Orantos |
| authorships[7].countries | ES |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210115082 |
| authorships[7].affiliations[0].raw_affiliation_string | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain. |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I2961216182 |
| authorships[7].affiliations[1].raw_affiliation_string | Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[7].institutions[0].id | https://openalex.org/I4210115082 |
| authorships[7].institutions[0].ror | https://ror.org/02g87qh62 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4387152914 |
| authorships[7].institutions[0].country_code | ES |
| authorships[7].institutions[0].display_name | Centro de Investigación Biomédica en Red |
| authorships[7].institutions[1].id | https://openalex.org/I2961216182 |
| authorships[7].institutions[1].ror | https://ror.org/04d0ybj29 |
| authorships[7].institutions[1].type | healthcare |
| authorships[7].institutions[1].lineage | https://openalex.org/I2961216182, https://openalex.org/I4210139293 |
| authorships[7].institutions[1].country_code | ES |
| authorships[7].institutions[1].display_name | Hospital Clínico San Carlos |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Maria Jose Núñez-Orantos |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain., Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[8].author.id | https://openalex.org/A5043709291 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-7259-554X |
| authorships[8].author.display_name | Noemí Cabello‐Clotet |
| authorships[8].countries | ES |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I2961216182 |
| authorships[8].affiliations[0].raw_affiliation_string | Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I4210115082 |
| authorships[8].affiliations[1].raw_affiliation_string | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain. |
| authorships[8].institutions[0].id | https://openalex.org/I4210115082 |
| authorships[8].institutions[0].ror | https://ror.org/02g87qh62 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4387152914 |
| authorships[8].institutions[0].country_code | ES |
| authorships[8].institutions[0].display_name | Centro de Investigación Biomédica en Red |
| authorships[8].institutions[1].id | https://openalex.org/I2961216182 |
| authorships[8].institutions[1].ror | https://ror.org/04d0ybj29 |
| authorships[8].institutions[1].type | healthcare |
| authorships[8].institutions[1].lineage | https://openalex.org/I2961216182, https://openalex.org/I4210139293 |
| authorships[8].institutions[1].country_code | ES |
| authorships[8].institutions[1].display_name | Hospital Clínico San Carlos |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Noemí Cabello-Clotet |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain., Hospital Clinico San Carlos, Madrid, Spain. |
| authorships[9].author.id | https://openalex.org/A5005269604 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-7795-5986 |
| authorships[9].author.display_name | Vicente Estrada |
| authorships[9].countries | ES |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210115082 |
| authorships[9].affiliations[0].raw_affiliation_string | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain. [email protected]. |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I2961216182 |
| authorships[9].affiliations[1].raw_affiliation_string | Hospital Clinico San Carlos, Madrid, Spain. [email protected]. |
| authorships[9].institutions[0].id | https://openalex.org/I4210115082 |
| authorships[9].institutions[0].ror | https://ror.org/02g87qh62 |
| authorships[9].institutions[0].type | facility |
| authorships[9].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4387152914 |
| authorships[9].institutions[0].country_code | ES |
| authorships[9].institutions[0].display_name | Centro de Investigación Biomédica en Red |
| authorships[9].institutions[1].id | https://openalex.org/I2961216182 |
| authorships[9].institutions[1].ror | https://ror.org/04d0ybj29 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I2961216182, https://openalex.org/I4210139293 |
| authorships[9].institutions[1].country_code | ES |
| authorships[9].institutions[1].display_name | Hospital Clínico San Carlos |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Vicente Estrada |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Centro de investigación biomédica en red en enfermedades infecciosas (CIBERINFEC), Madrid, Spain. [email protected]., Hospital Clinico San Carlos, Madrid, Spain. [email protected]. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://link.springer.com/content/pdf/10.1007/s10096-025-05150-4.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Underutilization of nirmatrelvir/ritonavir in eligible COVID-19 patients |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9993000030517578 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W3009669391, https://openalex.org/W3127156785, https://openalex.org/W3005417802, https://openalex.org/W3043486364, https://openalex.org/W3095730491, https://openalex.org/W4220712676, https://openalex.org/W4290085574, https://openalex.org/W3080407960, https://openalex.org/W3006642361, https://openalex.org/W4280491013 |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1007/s10096-025-05150-4 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S130127385 |
| best_oa_location.source.issn | 0934-9723, 1435-4373 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0934-9723 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | European Journal of Clinical Microbiology & Infectious Diseases |
| best_oa_location.source.host_organization | https://openalex.org/P4310319900 |
| best_oa_location.source.host_organization_name | Springer Science+Business Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s10096-025-05150-4.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | European Journal of Clinical Microbiology & Infectious Diseases |
| best_oa_location.landing_page_url | https://doi.org/10.1007/s10096-025-05150-4 |
| primary_location.id | doi:10.1007/s10096-025-05150-4 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S130127385 |
| primary_location.source.issn | 0934-9723, 1435-4373 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0934-9723 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | European Journal of Clinical Microbiology & Infectious Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310319900 |
| primary_location.source.host_organization_name | Springer Science+Business Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s10096-025-05150-4.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | European Journal of Clinical Microbiology & Infectious Diseases |
| primary_location.landing_page_url | https://doi.org/10.1007/s10096-025-05150-4 |
| publication_date | 2025-06-13 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4212904481, https://openalex.org/W4303423758, https://openalex.org/W4393852425, https://openalex.org/W4404190614, https://openalex.org/W4379212296, https://openalex.org/W4390531710, https://openalex.org/W4221050050, https://openalex.org/W4226236384, https://openalex.org/W4213152627 |
| referenced_works_count | 9 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 10 |
| citation_normalized_percentile.value | 0.28011996 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |